Your browser doesn't support javascript.
Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients.
Hu, Fei-Hong; Jia, Yi-Jie; Zhao, Dan-Yan; Fu, Xue-Lei; Zhang, Wan-Qing; Tang, Wen; Hu, Shi-Qi; Wu, Hua; Ge, Meng-Wei; Du, Wei; Shen, Wang-Qin; Zhu, Bin; Chen, Hong-Lin.
  • Hu FH; Medical School of Nantong University, Nantong, China.
  • Jia YJ; Medical School of Nantong University, Nantong, China.
  • Zhao DY; Medical School of Nantong University, Nantong, China.
  • Fu XL; Medical School of Nantong University, Nantong, China.
  • Zhang WQ; Medical School of Nantong University, Nantong, China.
  • Tang W; Medical School of Nantong University, Nantong, China.
  • Hu SQ; Medical School of Nantong University, Nantong, China.
  • Wu H; Medical School of Nantong University, Nantong, China.
  • Ge MW; Medical School of Nantong University, Nantong, China.
  • Du W; Medical School of Nantong University, Nantong, China.
  • Shen WQ; Medical School of Nantong University, Nantong, China.
  • Zhu B; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Nantong University, China; Nantong First People's Hospital, Nantong, China.
  • Chen HL; School of Public Health, Nantong University, Nantong, China. Electronic address: honglinyjs@126.com.
Clin Microbiol Infect ; 29(7): 835-844, 2023 Jul.
Article in English | MEDLINE | ID: covidwho-2308959
ABSTRACT

BACKGROUND:

Although the SARS-CoV-2 Omicron variant is considered to induce less severe disease, there have been no consistent results on the extent of the decrease in severity.

OBJECTIVES:

To compare the clinical outcomes of COVID-19-positive patients with Omicron and Delta variant infection. DATA SOURCES Searches were implemented up to 8 November 2022 in PubMed, Web of Science, BioRvix, and MedRvix. STUDY ELIGIBILITY CRITERIA Eligible studies were cohort studies reporting the clinical outcomes of COVID-19-positive patients with Omicron and Delta variant infection, including hospitalization, intensive care unit (ICU) admission, receiving invasive mechanical ventilation (IMV), and death.

PARTICIPANTS:

COVID-19-positive patients with Omicron and Delta variant infection. ASSESSMENT OF RISK OF BIAS Risk of bias was assessed employing the Newcastle-Ottawa Scale. METHODS OF DATA

SYNTHESIS:

Random-effect models were employed to pool the ORs and 95% CIs to compare the risk of clinical outcome. I2 was employed to evaluate the heterogeneity between studies.

RESULTS:

A total of 33 studies with 6 037 144 COVID-19-positive patients were included in this meta-analysis. In the general population of COVID-19-positive patients, compared with Delta, Omicron variant infection resulted in a decreased risk of hospitalization (10.24% vs. 4.14%, OR = 2.91, 95% CI = 2.35-3.60), ICU admission (3.67% vs. 0.48%, OR = 3.64, 95% CI = 2.63-5.04), receiving IMV (3.93% vs. 0.34%, OR = 3.11, 95% CI = 1.76-5.50), and death (2.40% vs. 0.46%, OR = 2.97, 95% CI = 2.17-4.08). In the hospitalized patients with COVID-19, compared with Delta, Omicron variant infection resulted in a decreased risk of ICU admission (20.70% vs. 12.90%, OR = 1.63, 95% CI = 1.32-2.02), receiving IMV (10.90% vs. 5.80%, OR = 1.65, 95% CI = 1.28-2.14), and death (10.72% vs. 7.10%, OR = 1.44, 95% CI = 1.22-1.71).

CONCLUSIONS:

Compared with Delta, the severity of Omicron variant infection decreased.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Topics: Variants Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2023 Document Type: Article Affiliation country: J.cmi.2023.03.017

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Topics: Variants Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2023 Document Type: Article Affiliation country: J.cmi.2023.03.017